CSK and breast carcinoma: Furthermore, HCK overexpression may be caused by suppression of C-terminal Src kinase and Cbp/PAG regulation pathway, such as in hepatocellular carcinoma 44, and by tyrosine phosphatases, such as in breast cancer 45.